C12P 7/6445 Glycerides
Introduced: January 2022
Full Title
Preparation of oxygen-containing organic compounds > Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats > Fatty acid esters > Glycerides
Classification Context
- Section:
- CHEMISTRY; METALLURGY
- Class:
- BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- Subclass:
- FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
Filing statistics
IPC C12P 7/6445 belongs to the parent subclass C12P, which recorded 146,875 patent applications worldwide between 2013 and 2023. Annual filings declined from 13,680 in 2013 to 13,214 in 2023 (-3%), peaking at 14,303 applications in 2022. The most active applicants in class C12 are CHINESE ACADEMY OF SCIENCES (10,330 applications), HARVARD UNIVERSITY (7,308 applications) and UNIVERSITY OF CALIFORNIA (6,383 applications).
Source: EPO PATSTAT, worldwide filings
5 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12P 7/6454 by esterification
- C12P 7/6458 by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
- C12P 7/6463 obtained from glyceride producing microorganisms, e.g. single cell oil
- C12P 7/6472 containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
- C12P 7/6481 Phosphoglycerides
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- CHINESE ACADEMY OF SCIENCES 10,330
- HARVARD UNIVERSITY US 7,308
- UNIVERSITY OF CALIFORNIA US 6,383
- JIANGNAN UNIVERSITY 5,144
- MONSANTO TECHNOLOGY US 4,121
- PIONEER HI-BRED INTERNATIONAL US 3,630
- REGENERON PHARMACEUTICALS US 3,515
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 3,499
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 3,371
- CJ CHEILJEDANG CORPORATION KR 3,361